Discontinued — last reported Q4 '22
Thermo Fisher Scientific Corporate And Other — Total Assets increased by 110.0% to $8.46B in Q4 2022 compared to the prior quarter.
An increase may indicate higher centralized cash reserves or investments in shared corporate infrastructure, while a decrease might suggest asset divestitures or improved allocation of resources to operating segments.
This metric represents the total value of assets held within the corporate or unallocated segment of the company. It typ...
Peers often report this as 'Corporate and Other' or 'Unallocated' assets, which typically fluctuate based on corporate treasury activities and centralized real estate holdings.
tmo_segment_corporate_other_total_assets| Q4 '21 | Q4 '22 | |
|---|---|---|
| Value | $4.03B | $8.46B |
| QoQ Change | — | +110.0% |
| YoY Change | — | +110.0% |